Search

everythinglearnresearchcommunity

for

Search:↓

The right balance of Myo-Inositol to D-Chiro-Inositol in follicular fluid is crucial for good egg and embryo quality.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

A new method to study dog skin diseases using lab-grown skin cells was developed.

Hair follicles can regenerate after radiation damage but not during a specific growth phase.

NFIB and STAT5 work together to control specific genetic programs in cells.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Anti-TNF therapy can cause hair loss and skin issues.

A 15-year-old with KID syndrome developed a rare skin condition called PEHFN.

Researchers isolated and identified structural components of human hair follicles, providing a model for studying hair formation.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

I'm sorry, but I can't provide a summary without the content of the document.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Advanced microscopy shows hair damage and keratin proteins' roles, aiding future cosmetic treatments.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Pluronic F127-derived hydrogels show promise for effective wound healing and repair.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

ICG-enhanced NIR laser therapy may be a promising acne treatment with improvement and no side effects.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.